EUPANTOL Side Effects

7013789-2 | Anaemia, Epistaxis, Respiratory Distress, Tracheal Haemorrhage
on Sep 13, 2010 Male patient from FRANCE , weighting 4.85 lb, was diagnosed with prophylaxis against gastrointestinal ulcer, endotracheal intubation, pain (What is pain?), pulmonary arterial hypertension and was treated with Eupantol (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, epistaxis, respiratory distress, tracheal haemorrhage. Eupantol dosage: . During the same period patient was treated with FENTANYL (View Fentanyl Review and Fentanyl Label ), PERFALGAN (View Perfalgan Review and Perfalgan Label ), REVATIO (View Revatio Review and Revatio Label ).

6435617-6 | Mucous Membrane Disorder, Stevens-johnson Syndrome
Patient was taking Eupantol (View Usage). Patient had the following side effects: mucous membrane disorder, stevens-johnson syndrome on Oct 30, 2009 from GERMANY Additional patient health information: Male patient , 48 years of age, . Eupantol dosage: Dose Form And Frequency Not Specified. During the same period patient was treated with RULID (Dose Form And Frequency Not Specified) (View Rulid Review and Rulid Label ). Patient was hospitalized.

6076047-9 | Anaphylactoid Shock, Burning Sensation
Adverse event was reported on Feb 03, 2009 by a Male patient taking Eupantol (View Usage) (Dosage: ) was diagnosed with oesophagitis and. Location: GERMANY , 27 years of age, After Eupantol was administered, patient had the following side effects: anaphylactoid shock, burning sensation. During the same period patient was treated with VOLTARENE (View Voltarene Review and Voltarene Label ). Patient was hospitalized.

6017349-1 | Anaphylactoid Shock, Burning Sensation
on Dec 17, 2008 Male patient from GERMANY , 27 years of age, was diagnosed with oesophagitis and was treated with Eupantol (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactoid shock, burning sensation. Eupantol dosage: . Patient was hospitalized.


5701672-1 | Dehydration, Diet Refusal, Hypersomnia, Hypokalaemia, Hyponatraemia, Hyporeflexia, Joint Hyperextension, Respiratory Acidosis
on Mar 31, 2008 Female patient from GERMANY , 95 years of age, was diagnosed with essential hypertension and was treated with Eupantol (View Usage). Patient had the following side effects: dehydration, diet refusal, hypersomnia, hypokalaemia, hyponatraemia, hyporeflexia, joint hyperextension, respiratory acidosis. Eupantol dosage: . During the same period patient was treated with VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ), ASPEGIC 1000 (View Aspegic 1000 Review and Aspegic 1000 Label ), MODURETIC 5 50 (View Moduretic 5-50 Review and Moduretic 5-50 Label ), ADANCOR (View Adancor Review and Adancor Label ). Patient was hospitalized.

5655683-5 | Mucous Membrane Disorder, Stevens-johnson Syndrome
Patient was taking Eupantol (View Usage). After Eupantol was administered, patient had the following side effects: mucous membrane disorder, stevens-johnson syndrome on Feb 26, 2008 from GERMANY Additional patient health information: Male patient , 48 years of age, . Eupantol dosage: Dose Form And Frequency Not Specified. During the same period patient was treated with RULID (Dose Form And Frequency Not Specified) (View Rulid Review and Rulid Label ). Patient was hospitalized.

5598872-0 | Fatigue, Malaise, Renal Failure Acute
Adverse event was reported on Nov 05, 2007 by a Female patient taking Eupantol (View Usage) (Dosage: ) was diagnosed with abdominal pain upper, pelvic pain (What is pelvic pain?), hypertension and. Location: FRANCE , 74 years of age, Patient experienced the following unwanted or unexpected effects: fatigue, malaise, renal failure acute. During the same period patient was treated with VISKALDIX (^1/2 Tablet Daily^) (View Viskaldix Review and Viskaldix Label ).

5531999-8 | Chest Pain, Erythema Nodosum, Headache, Mouth Ulceration, Pyrexia, Tachycardia, Uveitis, Vomiting
on Nov 26, 2007 Female patient from GERMANY , 32 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?), colitis and was treated with Eupantol (View Usage). Patient had the following side effects: chest pain (What is chest pain?), erythema nodosum, headache (What is headache?), mouth ulceration, pyrexia, tachycardia, uveitis, vomiting. Eupantol dosage: . During the same period patient was treated with ARAVA (View Arava Review and Arava Label ), LOPERAMIDE HCL (^df^) (View Loperamide Hcl Review and Loperamide Hcl Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), DAFALGAN (^df^) (View Dafalgan Review and Dafalgan Label ), ENBREL (View Enbrel Review and Enbrel Label ), APRANAX (View Apranax Review and Apranax Label ). Patient was hospitalized.

5522290-4 | Chest Pain, Erythema Nodosum, Headache, Mouth Ulceration, Pyrexia, Tachycardia, Uveitis, Vomiting
on Nov 15, 2007 Female patient from GERMANY , 32 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?), colitis and was treated with Eupantol (View Usage). After Eupantol was administered, patient had the following side effects: chest pain (What is chest pain?), erythema nodosum, headache (What is headache?), mouth ulceration, pyrexia, tachycardia, uveitis, vomiting. Eupantol dosage: . During the same period patient was treated with ARAVA (View Arava Review and Arava Label ), LOPERAMIDE HCL (^df^) (View Loperamide Hcl Review and Loperamide Hcl Label ), CORTANCYL (View Cortancyl Review and Cortancyl Label ), ACETAMINOPHEN (^df^) (View Acetaminophen Review and Acetaminophen Label ), ENBREL (View Enbrel Review and Enbrel Label ), APRANAX (View Apranax Review and Apranax Label ). Patient was hospitalized.

5458651-1 | Angioedema, Cytolytic Hepatitis, Eosinophilia, Hepatitis Cholestatic, Hypotension
Patient was taking Eupantol (View Usage). Patient experienced the following unwanted or unexpected effects: angioedema, cytolytic hepatitis, eosinophilia, hepatitis cholestatic, hypotension on Sep 11, 2007 from FRANCE Additional patient health information: Female patient , 44 years of age, was diagnosed with arthritis (What is arthritis?), arthropathy, essential hypertension and. Eupantol dosage: . During the same period patient was treated with TOPALGIC (View Topalgic Review and Topalgic Label ), COAPROVEL (View Coaprovel Review and Coaprovel Label ), INDOCIN (View Indocin Review and Indocin Label ). Patient was hospitalized.

5409843-9 | Dermatitis Bullous, Headache, Purpura
Adverse event was reported on Jul 31, 2007 by a Male patient taking Eupantol (View Usage) (Dosage: ) was diagnosed with gastritis, duodenitis, rectal haemorrhage and. Location: FRANCE , 48 years of age, Patient had the following side effects: dermatitis bullous, headache (What is headache?), purpura.

5404274-X | Cytolytic Hepatitis, Hepatic Steatosis, Hepatomegaly, Serum Ferritin Increased
on Jul 27, 2007 Female patient from FRANCE , 45 years of age, was diagnosed with oesophagitis, angina pectoris, hypothyroidism, diabetes mellitus, hyperlipidaemia and was treated with Eupantol (View Usage). After Eupantol was administered, patient had the following side effects: cytolytic hepatitis, hepatic steatosis, hepatomegaly, serum ferritin increased. Eupantol dosage: . During the same period patient was treated with DILTIAZEM HCL (View Diltiazem Hcl Review and Diltiazem Hcl Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), ACARBOSE (View Acarbose Review and Acarbose Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ). Patient was hospitalized.

5390278-2 | Arthralgia, Colitis Collagenous
on Jul 06, 2007 Female patient from FRANCE , 61 years of age, was diagnosed with breast cancer (What is breast cancer?), hypercholesterolaemia and was treated with Eupantol (View Usage). Patient experienced the following unwanted or unexpected effects: arthralgia, colitis collagenous. Eupantol dosage: . During the same period patient was treated with ARIMIDEX (View Arimidex Review and Arimidex Label ), KETOPROFEN (View Ketoprofen Review and Ketoprofen Label ), PIROXICAM (View Piroxicam Review and Piroxicam Label ), FENOFIBRATE (View Fenofibrate Review and Fenofibrate Label ), TAMOXIFEN CITRATE (^df^) (View Tamoxifen Citrate Review and Tamoxifen Citrate Label ), ABUFENE (View Abufene Review and Abufene Label ), LEVOTHYROXINE SODIUM (^df^) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), DAFALGAN (^df^) (View Dafalgan Review and Dafalgan Label ). Patient was hospitalized.

5237319-0 | Cytolytic Hepatitis, Thrombocytopenia
Patient was taking Eupantol (View Usage). Patient had the following side effects: cytolytic hepatitis, thrombocytopenia on Feb 01, 2007 from FRANCE Additional patient health information: Female patient , 70 years of age, . Eupantol dosage: . Patient was hospitalized.

5049117-1 | Blood Immunoglobulin E Increased, Dermatitis Bullous, Pemphigoid, Pruritus, Rash
Adverse event was reported on Apr 13, 2005 by a Male patient taking Eupantol (View Usage) (Dosage: 40 Mg/day) . Location: GERMANY , 64 years of age, After Eupantol was administered, patient had the following side effects: blood immunoglobulin e increased, dermatitis bullous, pemphigoid, pruritus, rash (What is rash?). During the same period patient was treated with THIOCOLCHICOSIDE (View Thiocolchicoside Review and Thiocolchicoside Label ), ZAMUDOL (View Zamudol Review and Zamudol Label ), NEXEN (100 Mg, Unk) (View Nexen Review and Nexen Label ), AMLOR (View Amlor Review and Amlor Label ), FRACTAL (View Fractal Review and Fractal Label ). Patient was hospitalized.

4635680-9 | Anaemia, Antinuclear Antibody Positive, Arthralgia, Blood Creatine Increased, Lupus-like Syndrome, Pain In Extremity, Red Blood Cell Sedimentation Rate Increased
on Mar 31, 2005 Female patient from , 82 years of age, was treated with Eupantol (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, antinuclear antibody positive, arthralgia, blood creatine increased, lupus-like syndrome, pain in extremity, red blood cell sedimentation rate increased. Eupantol dosage: 20 Mg 1x Per 1 Day. During the same period patient was treated with AMLOR (AMLODIPINE BESILATE,) (Some Dose Form Sometimes) (View Amlor (amlodipine Besilate,) Review and Amlor (amlodipine Besilate,) Label ), ATACAND (8 Mg 1x Per 1 Day) (View Atacand Review and Atacand Label ), FENOFIBRATE (160 Mg 1x Per 1 Day) (View Fenofibrate Review and Fenofibrate Label ), NIMESULIDE (NIMESULIDE,) (150 Mg 1x Per 1 Day) (View Nimesulide (nimesulide,) Review and Nimesulide (nimesulide,) Label ), NOCTRAN 10 (ACEPROMAZINE/ACEPROMETAZINE/CLORAZEPATE DIPOTASSIUM) (20 Mg 1x Per 1 Day) (View Noctran 10 (acepromazine/aceprometazine/clorazepate Dipotassium) Review and Noctran 10 (acepromazine/aceprometazine/clorazepate Dipotassium) Label ), COLCHIMAX (COLCHICINE/DICYCLOVERINE HCL) (View Colchimax (colchicine/dicycloverine Hcl) Review and Colchimax (colchicine/dicycloverine Hcl) Label ). Patient was hospitalized.